Exercise-induced changes in enzymatic O-methylation of catecholestrogens by erythrocytes of eumenorrheic women

Medicine and Science in Sports and Exercise

Volumn 29, Issue 12, 1997, Pages 1580-1587

  De Crée, Carl ^a   Van Kranenburg, Gerrit ^b   Geurten, Peter ^b   Fujimura, Yoshiyuki ^b   Keizer, Hans A ^b  

^a Inst Qyneco Endocrlnological Res   (Belgium)

^b NONE

Author keywords

AMENORRHEA; CATECHOLAMINES; CATECHOLESTROGENS; COMT; ESTROGENS; EXERCISE; MENSTRUAL CYCLE; NEUROTRANSMITTERS; NOREPINEPHRINE; WOMEN

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; AMENORRHEA; ARTICLE; CATECHOLAMINE RELEASE; ENZYME ACTIVITY; ESTROGEN METABOLISM; EXERCISE; FEMALE; HUMAN; MENSTRUAL CYCLE; NORMAL HUMAN;

ADOLESCENT; ADULT; AMENORRHEA; CATECHOL O-METHYLTRANSFERASE; ERYTHROCYTES; ESTROGENS, CATECHOL; EXERCISE; FEMALE; HUMANS; MENSTRUAL CYCLE; METHYLATION;

EID: 0344588915     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199712000-00006     Document Type: Article

References (36)

1. AXELROD, L. and R. TOMCHICK. Enzymatic o-methylation of epinephrine and other catechols. J. Biol. Chem. 233:702-705, 1958.
2. BALL, P. and R. KNUPPEN. Catecholestrogens (2- and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol. 93(Suppl. 232):1-128, 1980.
3. BALL., P., R. KNUPPEN, and M. HAUPT. Interactions between estrogens and catechol amines. III. Studies on the methylation of catechol estrogen, catechol amines and other catechols by the catechol-O-methyltransferase of human liver. J. Clin. Endocrinol. Metab. 34:736-746, 1972.
4. BATES, G., C. EDMAN, and J. PORTER. Metabolism of catechol estrogen by human erythrocytes. J. Clin. Endocrinol. Metab. 45:1120-1123, 1977.
5. BATES, G., C. EDMAN, and J. PORTER. Catechol-O-methyltransferase activity in erythrocytes of pregnant women. Am. J. Obstet. Gynecol. 131:553-557, 1978.
6. BONEN, A. and H. KEIZER. Athletic menstrual irregularity: endocrine responses to exercise and training. Physiol. Sports Med. 12:78-94, 1984.
7. DE CRÉE, C. The possible involvement of endogenous opioid peptides and catecholestrogens in provoking menstrual irregularities in women athletes. Int. J. Sports Med. Phys. Fitness 11:329-348, 1990.
8. DE CRÉE, C., P. BALL, B. SEIDLITZ, K. MANNHEIMER, G. VAN KRANENBURG, P. GEURTEN, and H. KEIZER. Effects of a training program on resting plasma 2-hydroxycatecholestrogen levels in eumenorrheic women. J. Appl. Physiol. 83:1551-1556, 1997.
9. DE CRÉE, C., P. BALL, B. SEIDLITZ, et al. Plasma 2-hydroxycatecholestrogen responses to acute submaximal and maximal exercise in untrained women. J. Appl. Physiol. 82:363-370, 1997.
10. DE CRÉE, C., G. VAN KRANENBURG, P. GEURTEN, Y. FUJIMORI, and H. KEIZER. 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer, Fertil. Steril. 67:505-516, 1997.
11. DILL, D. and D. COSTILL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37:247-248, 1979.0
12. FISHMAN, J., R. BOYAR, and L. HELLMAN. Influence of body weight on estradiol metabolism in young women. J. Clin. Endocrinol. Metab. 41:989-991, 1975.
13. FRISCH, R., G. WYSHAK, and N. ALBRIGHT. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br. J. Cancer 52:885-889, 1985.
14. GELBEK, H., O. HAUPT, and R. KNUPPEN. A simple chemical method for the analysis of catechol estrogens. Steroids 21:205218, 1973.
15. KEIZER, H., H. KUIPERS, and J. DE HAAN. Multiple hormonal responses to physical exercise in eumenorrheic trained and untrained women. Int. J. Sports Med. 8(Suppl.3):139-150, 1987.
16. KEIZER, H., H. KUIPERS, and J. DE HAAN. Effect of a 3-month endurance training program on metabolic and multiple hormonal responses to exercise. Int. J. Sports Med. 8(Suppl. 3):150-160, 1987.
17. KEIZER, H. and A. ROGOL. Physical exercise and menstrual cycle alterations: what are the mechanisms? Sports Med. 10:218-235, 1990.
18. KOPIN, I. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev. 37:333-364, 1985.
19. LEMON, H., J. HEIDEL, and J. RODRIGUEZ-SIERRA. Increased catechol estrogen metabolism as a risk factor for non-familial breast cancer. Cancer 69:457-465, 1992.
20. LI, S., R. PURDY, and J. LI. Variations in catechol O-methyltransferasc activity in rodent tissues: possible role in estrogens carci- nogenicity. Carcinogenesis 10:63-67, 1989.
21. LOUCKS, A. and S. HORVATH. Exercise-induced stress responses of amenorrheic and eumenorrheic runners. J. Clin. Endocrinol. Metab. 59:1109-1120, 1984.
22. MCGRAIL, J., A. BUNEN, and A. BELCASTRO. Dependence of lactate removal on muscle metabolism in man. Eur. J. Appl. Physiol. 39:89-97, 1978.
23. MCLEOD, H., L. FANG, and L. XIAO-LONG. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J. Pharmacol. Exp. Ther. 270:26-29, 1994.
24. NAKAGAWA, A., R. OH'UCHI, and I. YOSHIZAWA. The effect of hydrogen ion concentrations on enzymatic O-methylation of catechol estrogen. J. Pharmacobiodyn. 2:365-373, 1979.
25. REZNIKOV, A. and N. NOSENKO. Catecholamines in steroid-dependent brain development. J. Steroid Biochem. Mol. Biol. 53:349-353, 1995.
26. RUSSEL, J., A. DE CHERNEY, and D. COLLINS. The role of β- endorphin and catechol estrogens on the hypothalamic-pituitary axis in female athletes. Fertii Steril. 42:690-695, 1984.
27. SAGARA, Y., Y. OKATANI, and T. KIRIYAMA. A rapid, sensitive and quantitative high-performance liquid Chromatographic determination of catecholestrogens in human serum. Asia Oceania J. Obstet, Gynaecol. 11:597-604, 1985.
28. SCHULTZ, E., S. TARPILA, A. BÄCKSTRÖM, and A. GORDIN. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone. Eur. J. Clin. Pharmacol. 40:577-580, 1991.
29. SNOW, R., R. BARBIERI, and R. FRISCH. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J. Clin. Endocrinol. Metab. 69:369, 1989.
30. SUNDBERG, S., M. SCHEININ, and P. OJALA-KARLSSON. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone. Clin. Pharmacol. Ther. 48:356-364, 1990.
31. SUNDBERG, S., M. SCHEININ, and P. OJALA-KARLSSON. The effects of the COMT inhibitor nitecapone for one week on exercise haemo- dynamics and catecholamine disposition. Eur. J. Clin. Pharmacol. 44:287-290, 1993.
32. SUZUKI, E., K. SAEGUSA, and T. ANJO. Enzymatic O-methylation of catechol estrogens in red blood cells: differences in animal species and strains. Steroids 58:540-546, 1993.
33. SUZUKI, E., K. SAEGUSA, and Y. MATSUKI. Assay of enzymic O-methylation of catechol oestrogens by high-performance liquid chromatography. J. Chromatogr. 617:221-225, 1993.
34. WEINSHILBAUM, R. and F. RAYMOND. Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am. J. Hum. Genet. 29:125-135, 1977.
35. ZHU, B. and J. LIEHR. Inhibition of the catechol-O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by catecholamines. Implications for the mechanism of estrogen-induced carcinogenesis. Arch. Biochem. Biophys. 304:248-256, 1993.
36. ZHU, B., D. ROY, and J. LIEHR. The carcinogenic activity of ethinyl estrogen is determined by both their hormonal characteristics and their conversion to catechol metabolites. Endocrinology 132:577583, 1993.